» Articles » PMID: 33609277

Effects of Pre-dialysis Resistance Training on Sarcopenia, Inflammatory Profile, and Anemia Biomarkers in Older Community-dwelling Patients with Chronic Kidney Disease: a Randomized Controlled Trial

Abstract

Background: Sarcopenia and chronic kidney disease (CKD) have been associated with negative outcomes in older people, including inflammatory profile and anemia biomarkers.

Aims: To investigate the effects of pre-dialysis resistance training (RT) on sarcopenia, inflammatory profile, and anemia biomarkers in older patients with CKD.

Methods: A total of 107 patients with CKD (65.4 ± 3.7 years) were randomly allocated into four groups: sarcopenic RT (n = 37), non-sarcopenic RT (n = 20), sarcopenic control (n = 28), and non-sarcopenic control (n = 22). DXA and handgrip strength were used to classify sarcopenia according to EWGSOP-2. Treatment groups underwent a 24-week intervention with RT before each dialysis session, three times per week. Blood sample analysis for ferritin, hepcidin, iron availability, and inflammatory profile (TNFα, IL-6, and IL-10) was conducted. All-cause mortality was recorded over 5 years.

Results: Sarcopenic RT group increased iron availability after the intervention, while their counterparts decreased. Ferritin and hepcidin significantly decreased in sarcopenic RT group. RT elicited a reduction in both TNFα and IL-6, while increasing IL-10 in both intervention groups. The rate of sarcopenic subjects substantially decreased after the intervention period (from 37 to 17 in the RT group; p = 0.01). The proportion of deaths was higher (P = 0.033) for sarcopenic subjects (Controls 35.7% vs RT 29.7%) when compared to non-sarcopenic subjects (Controls 18% vs RT 10%). The proportion of deaths decreased according to the randomization group (X2 = 8.704; P < 0.1).

Conclusions: The 24-week RT intervention elicited a better sarcopenia status, better inflammatory profile, and improved anemia biomarkers. Sarcopenia was associated with higher mortality rate in older patients with CKD.

Citing Articles

Aging and chronic kidney disease: epidemiology, therapy, management and the role of immunity.

Tang Y, Jiang J, Zhao Y, Du D Clin Kidney J. 2025; 17(9):sfae235.

PMID: 40034487 PMC: 11873799. DOI: 10.1093/ckj/sfae235.


Iron homeostasis and ferroptosis in muscle diseases and disorders: mechanisms and therapeutic prospects.

Ru Q, Li Y, Zhang X, Chen L, Wu Y, Min J Bone Res. 2025; 13(1):27.

PMID: 40000618 PMC: 11861620. DOI: 10.1038/s41413-024-00398-6.


The impact of different exercise modalities on chronic kidney disease: an umbrella review of meta-analyses.

Correa H, Rosa T, Santos R, Mestrinho V, Aquino T, Santos W Front Physiol. 2025; 15():1444976.

PMID: 39835199 PMC: 11743718. DOI: 10.3389/fphys.2024.1444976.


Whole body resistance training on functional outcomes of patients with Stage 4 or 5 chronic kidney disease: A systematic review.

Abrahim S, Steele A, Voth J, Krepinsky J, Lanktree M, Hawke T Physiol Rep. 2024; 12(15):e16151.

PMID: 39134506 PMC: 11319065. DOI: 10.14814/phy2.16151.


Skeletal Muscle Injury in Chronic Kidney Disease-From Histologic Changes to Molecular Mechanisms and to Novel Therapies.

Heitman K, Alexander M, Faul C Int J Mol Sci. 2024; 25(10).

PMID: 38791164 PMC: 11121428. DOI: 10.3390/ijms25105117.


References
1.
Levey A, Coresh J . Chronic kidney disease. Lancet. 2011; 379(9811):165-80. DOI: 10.1016/S0140-6736(11)60178-5. View

2.
Masson P, Webster A, Hong M, Turner R, Lindley R, Craig J . Chronic kidney disease and the risk of stroke: a systematic review and meta-analysis. Nephrol Dial Transplant. 2015; 30(7):1162-9. DOI: 10.1093/ndt/gfv009. View

3.
Xie Y, Bowe B, Mokdad A, Xian H, Yan Y, Li T . Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018; 94(3):567-581. DOI: 10.1016/j.kint.2018.04.011. View

4.
Briggs A, Cross M, Hoy D, Sanchez-Riera L, Blyth F, Woolf A . Musculoskeletal Health Conditions Represent a Global Threat to Healthy Aging: A Report for the 2015 World Health Organization World Report on Ageing and Health. Gerontologist. 2016; 56 Suppl 2:S243-55. DOI: 10.1093/geront/gnw002. View

5.
Cruz-Jentoft A, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T . Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018; 48(1):16-31. PMC: 6322506. DOI: 10.1093/ageing/afy169. View